Emcure Pharmaceuticals Ltd (EMCURE) — Defensive Interval Ratio
Emcure Pharmaceuticals Ltd (EMCURE) has a Defensive Interval Ratio of 239 days as of March 2026. Defensive assets of Rs25.63 Billion (cash Rs-, short-term investments Rs-, receivables Rs25.63 Billion) cover 239 days of daily cash needs of Rs107.18 Million/day. See EMCURE working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Emcure Pharmaceuticals Ltd Defensive Interval Ratio (2022–2026)
This chart shows how Emcure Pharmaceuticals Ltd's Defensive Interval Ratio has evolved across 5 annual periods from 2022 to 2026. As of March 2026, the ratio stands at 239 days, meaning defensive assets of Rs25.63 Billion can fund 239 days of operations without new revenue. See how leveraged is Emcure Pharmaceuticals Ltd's balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Emcure Pharmaceuticals Ltd (2022–2026)
The table below presents the year-by-year Defensive Interval Ratio for Emcure Pharmaceuticals Ltd from 2022 to 2026, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is Emcure Pharmaceuticals Ltd worth.
| Year | DIR (days) | Defensive Assets (INR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2026 | 239 days | Rs25.63 Billion | Rs107.18 Million/day | Rs- | Rs- | ▼ -52 days |
| 2025 | 292 days | Rs21.31 Billion | Rs73.10 Million/day | Rs- | Rs760.43 Million | ▲ +47 days |
| 2024 | 244 days | Rs21.48 Billion | Rs87.96 Million/day | Rs- | Rs2.89 Billion | ▲ +20 days |
| 2023 | 224 days | Rs18.53 Billion | Rs82.72 Million/day | Rs- | Rs2.04 Billion | ▲ +45 days |
| 2022 | 179 days | Rs14.54 Billion | Rs81.23 Million/day | Rs- | Rs1.46 Billion | — |